--- title: "Early Phase Center of Excellence for Biotechs - Avance Clinical" description: "Avance Clinical has launched its Early Phase Center of Excellence for Biotechs, designed to deliver scientific rigor, innovative trial design, global regulatory insight, and operational excellence for smarter, more efficient early phase trials with significant cost savings for biotechs worldwide." canonical: "https://www.avancecro.com/early-phase-center-of-excellence-for-biotechs/" generated: "2026-09-21T01:52:44+00:00" --- # **[Early Phase](https://www.avancecro.com/cro/phase-i-early-phase/) Center of Excellence for Biotechs** Accelerating First-in-Human and Proof-of-Concept Milestones **Avance Clinical, the Australia-based global CRO partner for biotechs, has been a leader in [Early Phase](https://www.avancecro.com/cro/phase-i-early-phase/) clinical research for more than 30 years.** With operations across [Australia](https://www.avancecro.com/the-australian-advantage/), New Zealand, [North America](https://www.avancecro.com/the-north-american-advantage/), [Asia](https://www.avancecro.com/the-asia-advantage/), and Europe, the company delivers biotech sponsors both deep local expertise and global reach. Expanding on this legacy, Avance Clinical has launched its **Early Phase Center of Excellence for Biotechs**, designed to deliver scientific rigor, innovative trial design, global regulatory insight, and operational excellence for smarter, more efficient early phase trials with significant cost savings for biotechs worldwide. The Center of Excellence solves the challenges facing early phase biotechs, including approval delays, slow site startups, and inefficient trial designs that drive up costs and compromise data quality. Learn more [Request A Proposal](https://www.avancecro.com/request-a-proposal/) ![](https://www.avancecro.com/wp-content/uploads/2026/08/Why-Early-CRO-Choice-Is-Critical-To-Accelerating-Delivery-Of-Your-Clinical-Program-aspect-ratio-1600-975-1-916x916.jpg) ## GET IN TOUCH WITH OUR **CLINICAL TRIAL EXPERTS** Three decades of experience in biotech drug development [Connect with us](https://www.avancecro.com/request-a-proposal/) ## How Does This Support **[Early Phase](https://www.avancecro.com/cro/phase-i-early-phase/) Biotechs**? [Request a proposal](https://www.avancecro.com/request-a-proposal/) ### Design Before Execution Instead of retrofitting protocols after study initiation, our early-phase specialists co-design study plans with sponsors to anticipate safety, PK/PD, biomarker, and translational requirements upfront. ### Regulatory Acceleration Leveraging Australia’s efficient regulatory environment — with no IND required and 5–6 week startup timelines — our regulatory strategists guide CTN/CTX pathways and streamline ethics and submission processes for faster approvals. ### Operational Readiness From Day 1 With deep partnerships across Australia’s leading Phase I units and proven global site networks, our teams minimize startup risks and ensure rapid patient recruitment and first-dose timelines. ### Continuity Across Phases Sponsors no longer need to change providers as their programs evolve. Our integrated model provides consistent oversight, quality, and data standards from early development through regulatory submission. ### Investor and Partner Confidence By combining scientific depth, regulatory clarity, and operational precision, we give sponsors and investors the confidence that early data will drive informed, value-creating decisions. To accelerate their clinical programs. ### A Global Network of Early-Phase Expertise The Center of Excellence brings together therapeutic, regulatory, and operations leaders across Avance Clinical’s global footprint — including Australia, New Zealand, Asia, North America, and Europe. This interconnected network provides biotech sponsors with local insight and global alignment — ensuring study designs that meet both regulatory expectations and real-world patient needs. ### What This Means for **Biotech Sponsors** - Streamlined pathway from preclinical to [Phase I](https://www.avancecro.com/cro/phase-i-early-phase/) and proof-of-concept - Faster study startup — 5-6 weeks from final protocol to study approval - Smarter protocol designs that reduce amendments and delays - Regulatory support across multiple regions - Data and operational continuity across all trial phases - Increased stakeholder and investor confidence ![](https://www.avancecro.com/wp-content/uploads/2025/10/Bloods-aspect-ratio-1600-975-916x916.png) ### Meet Our **Expert Team** [![Liahna Toy](https://www.avancecro.com/wp-content/uploads/2025/10/Liahna-Toy_104-scaled-aspect-ratio-800-920.jpg)](https://www.avancecro.com/meet-the-team/liahna-toy/) ### [Liahna Toy](https://www.avancecro.com/meet-the-team/liahna-toy/) Senior Vice President & Head of Early Phase Center of Excellence [![Liahna Toy's LinkedIn Profile](https://www.avancecro.com/wp-content/themes/tpt/img/svg/icon-linkedin.svg)](https://linkedin.com/in/liahna-toy) [Read more](https://www.avancecro.com/meet-the-team/liahna-toy/) [![Ben Edwards](https://www.avancecro.com/wp-content/uploads/2026/07/Ben-Edwards-2-Pic-49-1-scaled-aspect-ratio-800-920.jpg)](https://www.avancecro.com/meet-the-team/ben-edwards/) ### [Ben Edwards](https://www.avancecro.com/meet-the-team/ben-edwards/) Chief Operating Officer [![Ben Edwards's LinkedIn Profile](https://www.avancecro.com/wp-content/themes/tpt/img/svg/icon-linkedin.svg)](https://www.linkedin.com/in/ben-edwards-9b2a3613/) [Read more](https://www.avancecro.com/meet-the-team/ben-edwards/) ### Partner with **Avance Clinical** With over 30 years of experience, operations spanning [Australia](https://www.avancecro.com/the-australian-advantage/), New Zealand, [Asia](https://www.avancecro.com/the-asia-advantage/), [North America](https://www.avancecro.com/the-north-american-advantage/), and Europe, and a reputation for award-winning CRO leadership, Avance Clinical’s [Early Phase](https://www.avancecro.com/cro/phase-i-early-phase/) Center of Excellence for Biotechs delivers a new standard of support for biotech innovation. From preclinical through regulatory submission, our integrated, global approach ensures your molecule’s early-phase success — setting the foundation for future clinical and commercial milestones. [Contact us](https://www.avancecro.com/request-a-proposal/) to learn how our early-phase expertise can accelerate your path to proof-of-concept. ### **Find out more** - Access up to 43.5% Australian Government R&D Tax Rebate with the [Australian Advantage](https://www.avancecro.com/the-australian-advantage/) for [Early Phase](https://www.avancecro.com/cro/phase-i-early-phase/) biotechs - Discover Avance Clinical’s [ClinicReady program](https://www.avancecro.com/cro/preclinical-clinicready/) for pre-clinical biotechs ## BOOK A MEETING